EX-23.1 3 brhc10022952_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Immunocore Limited:
We consent to the use of our report incorporated by reference herein.
Our report refers to a change in the method of accounting for leases as of January 1, 2019, due to the adoption of IFRS 16, Leases.

London, United Kingdom
April 12, 2021